Fat in the liver is not the whole diagnosis
Metabolic dysfunction-associated steatotic liver disease, or MASLD, describes fatty liver associated with metabolic risk factors. Many people have no obvious symptoms. The important question is not only whether fat is present but whether inflammation or significant scarring may also be present.
What assessment may include
The clinician reviews weight, diabetes, blood pressure, lipids, medicines, alcohol exposure and other possible liver conditions. Blood-based fibrosis scores and liver stiffness tests may help when suitable. Normal liver enzymes do not reliably exclude important scarring.
What supports long-term improvement?
Sustainable dietary changes, suitable physical activity and gradual weight reduction when indicated are central measures. Diabetes and cardiovascular risk also need attention. Avoid crash diets and unproven liver-cleansing remedies. Medicine decisions depend on the individual disease stage and should be discussed with a clinician.
Prepare for a useful conversation
Bring previous ultrasound reports, liver tests, diabetes and lipid results, and a list of medicines and supplements. Ask whether you need fibrosis assessment, what goals are realistic and when you should return. A written follow-up plan helps distinguish routine monitoring from symptoms requiring earlier review.
New jaundice, rapidly increasing abdominal swelling, bleeding or confusion needs prompt medical assessment rather than being attributed to simple fatty liver.
Professional reference: EASL–EASD–EASO MASLD guideline executive summary. Liver consultations · Nutrition information. General education only; no diagnosis or treatment is determined by this page.